PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extracts showed remarkable tyrosinase enzyme inhibitory effects (IC50 20.39 ± 0.44 µg/mL) [PMID:31518762]
Crude extracts showed inhibition of α-glycosidase activity [PMID:32538679]
Crude extracts did not show any inhibition of urease [PMID:32538679]
New pyridine alkaloids (-)-vinmajpyridines A-C were not active against GITC-3#, GITC-18#, U-87MG, T98G, or A-549 cell lines at 20 µg/mL [PMID:28620872]
Alkaloid extracts demonstrated high lipid peroxidation inhibitory and DPPH radical scavenging activities [PMID:22816294]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 1197413 (1975) — Monoterpenoid alkaloid from Vinca major. · Planta medica
- 2.PMID: 26850347 (2016) — Non-alkaloid constituents of Vinca major. · Chinese journal of natural medicines
- 3.PMID: 17402086 (1982) — Alkaloids of Vinca major cv. Variegata. · Planta medica
- 4.PMID: 36990229 (2023) — Missed chances? Sequestration and non-sequestration of alkaloids by moths (Lepidoptera). · Toxicon : official journal of the International Society on Toxinology
- 5.PMID: 28620872 (2017) — Three New Pyridine Alkaloids from Vinca major Cultivated in Pakistan. · Natural products and bioprospecting